Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-3tknxyPhase 1Completed
Phase 1, open-label trial of meloxicam (3 arms), sponsored by Centro de Ciências Biológicas e da Saúde da UFSCar. Primary endpoint: Inflammatory activity during menstruation. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-3tknxy.